Patel Bimalkumar N, Krishnaveni N, Jivani Nurrrudin P, Khodakiya Akruti S, Khodakiya Moorti S, Parida Saswat K
Department of Pharmaceutical Analysis, C.U. Shah College of Pharmacy and Research, Wadhwan, Gujarat, India.
Department of Pharmaceutical Analysis, J.S.S. College of Pharmacy, Ooty, Tamil Nadu, India.
Ayu. 2014 Oct-Dec;35(4):438-41. doi: 10.4103/0974-8520.159020.
Calcium sandoz-250 is an Ayurvedic calcium supplement, containing Khatika Churna. Bioavailability study of the formulation is essential for estimation of peak plasma concentration (C max), time to C max and rate of absorption.
To evaluate the absorption parameters of calcium sandoz-250 in albino rats by atomic absorption spectroscopic (AAS) method.
Study was carried out as a single dose, open-label, randomized study. Estimation of calcium was carried out by AAS, after validating the method for a few parameters for the estimation. Pharmacokinetic parameters such as C max, time to peak concentration (T max), area under the plasma concentration - time curve were calculated for calcium on administration of calcium sandoz-250.
Linearity curve was plotted for 0.5-2.5 ppm, given R (2) value 0.9975. The C max, i.e. C max after administration of calcium sandoz-250 was 0.793 mg/ml at 90 min (T max). Measurable calcium-blood levels were noticed in all subjects up to 3.0 h after administration of calcium sandoz-250.
Calcium sandoz-250, consisting of Khatika Churna, increases the blood calcium level in albino rats.
山德士钙250是一种阿育吠陀钙补充剂,含有卡蒂卡 churn(一种草药配方,具体成分未详细说明,音译保留)。该制剂的生物利用度研究对于估计血浆峰值浓度(Cmax)、达到Cmax的时间和吸收速率至关重要。
通过原子吸收光谱法(AAS)评估山德士钙250在白化病大鼠中的吸收参数。
本研究作为单剂量、开放标签、随机研究进行。在对用于估计的几个参数进行方法验证后,通过AAS进行钙的估计。在给予山德士钙250后,计算钙的药代动力学参数,如Cmax、达到峰值浓度的时间(Tmax)、血浆浓度 - 时间曲线下面积。
绘制了0.5 - 2.5 ppm的线性曲线,R(2)值为0.9975。给予山德士钙250后的Cmax,即在90分钟(Tmax)时为0.793 mg/ml。在给予山德士钙250后长达3.0小时的所有受试者中均检测到可测量的血钙水平。
由卡蒂卡 churn组成的山德士钙250可提高白化病大鼠的血钙水平。